It appears a research facility is going to use Recce 327. They cannot use a simple Letter of Agreement as Recce 327 is patented so they must use a Material Research Agreement similar to a Material Transfer Agreement. The recipient research facility will utilize the Recce 327 IP which needs to be well protected.
It could be research for Covid or something else.Material transfer agreement
From Wikipedia, the free encyclopediaJump to navigationJump to searchA Material transfer agreement (MTA) is a contract that governs the transfer of tangible research materials between two organizations, when the recipient intends to use it for his or her own research purposes. The MTA defines the rights of the provider and the rights and obligations of the recipient with respect to the materials and any progeny, derivatives, or modifications. Biological materials, such as reagents, cell lines, plasmids, and vectors, are the most frequently transferred materials, but MTAs may also be used for other types of materials, such as chemical compounds, mouse models, and even some types of software.
MTA types[edit]
Three types of MTAs are most common at academic institutions: transfer between academic or research institutions, transfer from academia to industry, and transfer from industry to academia. Each calls for different terms and conditions.[1]
For simple transfers not involving intellectual property, the NIH recommends a Simple Letter Agreement. [2] For materials that may be patented or for which more protection is desired, the Uniform Biological Material Transfer Agreement (UBMTA) can be used. Many U.S. educational institutions have signed the UBMTA Master Agreement. AUTM (previously the Association of University Technology Managers) serves as the repository for the original UBMTA Master Agreements and maintains the list of the signatories. [3] Signatories to the UBMTA only have to sign an Implementing Letter with the details of the particular transfer since they have already agreed to all the terms of the Master Agreement
- Forums
- ASX - By Stock
- Ann: Trading Halt
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.33%
!
31.0¢

It appears a research facility is going to use Recce 327. They...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 18938 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 0.300 |
2 | 34803 | 0.295 |
2 | 50000 | 0.290 |
4 | 131061 | 0.285 |
10 | 251389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 18938 | 1 |
0.320 | 5000 | 1 |
0.325 | 12600 | 1 |
0.330 | 114230 | 1 |
0.350 | 51319 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online